Haberler: Kovid-19

Kovid-19

İçinde

("Covid 19","Kovid 19","Koronavirüs","Korona virüs","Biontech","Sinovac","Delta ","Lambda ","Covid19","Kovid19","Covid-19","Kovid-19","Omicron ","Omikron ")

kelimelerinden biri ile,

(" aşı","vaccine","varyant","variant","pandemi","vaka "," dalga","pandemic","salgın")

kelimelerinden birinin aynı anda geçtiği haberler

Cuma, 20 Mayıs 2022, 12:04 ÖÖ	Haber Kaynağı: Çeşitli Haber Siteleri Impact of the COVID-19 Pandemic on Administration of Selected Routine Childhood and Adolescent Vaccinations - 10 U.S. Jurisdictions, March-September 2020 This report describes trends in administered childhood and adolescent vaccinations during the COVID-19 pandemic. https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=423450

Cuma, 20 Mayıs 2022, 12:04 ÖÖ	Haber Kaynağı: Çeşitli Haber Siteleri Patterns in COVID-19 Vaccination Coverage, by Social Vulnerability and Urbanicity - United States, December 14, 2020-May 1, 2021 Disparities in county-level vaccination coverage by social vulnerability have increased as vaccine eligibility has expanded. By May 2021, vaccination coverage was lower among adults living in counties with low socioeconomic status and higher percentages of households with children, single parents, and people with disabilities. https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=423045

Cuma, 20 Mayıs 2022, 12:04 ÖÖ	Haber Kaynağı: Çeşitli Haber Siteleri Excess Death Estimates in Patients with End-Stage Renal Disease - United States, February-August 2020 Based on the national trend in ESRD deaths during the first 7 months of the U.S. COVID-19 pandemic (February-August 2020), an estimated 8.7-12.9 excess deaths per 1,000 patients or 6,953-10,316 excess deaths in a population of 798,611 U.S. ESRD patients occurred. https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=423046

Cuma, 20 Mayıs 2022, 12:04 ÖÖ	Haber Kaynağı: Çeşitli Haber Siteleri COVID-19 Vaccine Breakthrough Infections Reported to CDC - United States, January 1-April 30, 2021 As of April 30, 2021, approximately 101 million people in the U.S. had been fully vaccinated against COVID-19. Almost 10,300 COVID-19 vaccine breakthrough infections were reported from 46 states and territories. Vaccine breakthrough infections occur in only a small fraction of all vaccinated people. https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=422857

Cuma, 20 Mayıs 2022, 12:04 ÖÖ	Haber Kaynağı: Çeşitli Haber Siteleri The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Adolescents Aged 12-15 Years - United States, May 2021 In May 2021, after a systematic review of all available data, the Advisory Committee on Immunization Practices made an interim recommendation for use of the Pfizer-BioNTech COVID-19 vaccine in adolescents aged 12-15 years for the prevention of COVID-19. https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=422060

Cuma, 20 Mayıs 2022, 12:04 ÖÖ	Haber Kaynağı: Çeşitli Haber Siteleri Interim Estimates of Vaccine Effectiveness of Pfizer-BioNTech and Moderna COVID-19 Vaccines Among Health Care Personnel - 33 U.S. Sites, January-March 2021 The first U.S. multisite test-negative design vaccine effectiveness study among HCP found a single dose of Pfizer-BioNTech or Moderna COVID-19 vaccines to be 82% effective against symptomatic COVID-19 and 2 doses to be 94% effective. https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=422061

Cuma, 20 Mayıs 2022, 12:04 ÖÖ	Haber Kaynağı: Çeşitli Haber Siteleri Identification of and Surveillance for the SARS-CoV-2 Variants B.1.427 and B.1.429 - Colorado, January-March 2021 On January 24, the Colorado Department of Public Health and Environment (CDPHE) identified the first Colorado case of COVID-19 attributed to the B.1.427 and B.1.429 variants. To improve convenience sampling to identify and track emerging variants, CDPHE established a 30-site statewide sentinel surveillance system. https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=421658

Cuma, 20 Mayıs 2022, 12:04 ÖÖ	Haber Kaynağı: Çeşitli Haber Siteleri Anxiety-Related Adverse Event Clusters After Janssen COVID-19 Vaccination - Five U.S. Mass Vaccination Sites, April 2021 Five mass vaccination sites reported 64 anxiety-related events, including 17 events of syncope (fainting) after receipt of Janssen COVID-19 vaccine. The reporting rates of syncope to VAERS after Janssen COVID-19 and influenza vaccines (2019-20) were 8.2 and 0.05 per 100,000 doses, respectively. https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=421542

Cuma, 20 Mayıs 2022, 12:04 ÖÖ	Haber Kaynağı: Çeşitli Haber Siteleri Safety Monitoring of the Janssen (Johnson & Johnson) COVID-19 Vaccine - United States, March-April 2021 Nearly 8 million doses of the Janssen COVID-19 vaccine had been administered. Review of safety monitoring data found that 97% of reported reactions after vaccine receipt were nonserious, consistent with preauthorization clinical trials data. A total of 17 thrombotic events with thrombocytopenia were detected, including three non-CVST events. https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=421539

Cuma, 20 Mayıs 2022, 12:04 ÖÖ	Haber Kaynağı: Çeşitli Haber Siteleri Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years - United States, January-March 2021 In U.S. hospitals during January-March 2021, receipt of Pfizer-BioNTech or Moderna COVID-19 vaccines was 94% effective against COVID-19 hospitalization among fully vaccinated adults and 64% effective among partially vaccinated adults aged ≥65 years. https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=421438